Status:
RECRUITING
Predictive Modelling of the Intraoperative Train-of-Four (TOF) Ratio
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Analyse Neuromuscular Monitoring for Developing a Model to Predict TOF Ratio During Anesthesia
Eligibility:
All Genders
18+ years
Brief Summary
Neuromuscular Blocking Agents (NMBAs) are routinely administered to patients in a multiplicity o anaesthetic settings in order to paralyze and impede (re)active muscular contraction. The availability ...
Eligibility Criteria
Inclusion
- Adult patients (18 years old and above) receiving General Anesthesia for noncardiac surgery requiring the use of a neuromuscular blocking agent.
- Administration of General Anesthesia by means of Total Intravenous Anesthesia technique.
- Use of Rocuronium as a neuromuscular blocking agent.
Exclusion
- Use of different types of neuromuscular blocking agents for the same patient within the same surgical procedure
- Known Neuromuscular diseases/syndromes judged to condition accurate neuromuscular monitoring.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04518761
Start Date
July 1 2020
End Date
December 31 2026
Last Update
May 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Jette, Brussels Capital, Belgium, 1090
2
AZ Sint Jan
Bruges, WV, Belgium, 8000